MRT-048

N/A

Report date: 2024/07/02 14:10:34

NME

Base Information

Drug NameMRT-048

Drug Alias NameMRT-048

ClassificationSmall moleculesSmall molecules > Molecular Glue

Mechanisms of ActionCereblon modulatorsEukaryotic peptide chain release factor GTP-binding subunit ERF3A modulatorsProtein cereblon/E3 ubiquitin-protein ligase ZFP91 degraders

TargetsCereblonEukaryotic peptide chain release factor GTP-binding subunit ERF3AProtein cereblon/E3 ubiquitin-protein ligase ZFP91

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMonte Rosa Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesMonte Rosa Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A